User contributions
Jump to navigation
Jump to search
- 16:49, 4 November 2022 diff hist -10 User:Alikhaki Bio Tag: visualeditor
- 16:48, 4 November 2022 diff hist +18 N File:Ali Raza Khaki, MD.jpg current
- 19:00, 30 March 2022 diff hist +44 Urothelial carcinoma →Regimen variant #3 (ddMVAC), 6 cycles {{#subobject:7ae9e3|Variant=1}}
- 18:59, 30 March 2022 diff hist +654 Urothelial carcinoma →Regimen variant #2, split-dose cisplatin Tag: visualeditor-switched
- 18:48, 30 March 2022 diff hist +385 Urothelial carcinoma →Regimen variant #3, single-dose cisplatin & 1250mg/m2 gemcitabine {{#subobject:221dfe|Variant=1}}
- 18:45, 30 March 2022 diff hist -74 Urothelial carcinoma →Regimen variant #3, single-dose cisplatin & 1250mg/m2 gemcitabine Tag: visualeditor
- 18:42, 30 March 2022 diff hist +14 Urothelial carcinoma →Regimen variant #3, single-dose cisplatin & 1250mg/m2 gemcitabine {{#subobject:221dfe|Variant=1}}
- 18:41, 30 March 2022 diff hist +1,046 Urothelial carcinoma →Cisplatin & Gemcitabine (GC) {{#subobject:d08e11|Regimen=1}} Tag: visualeditor-switched
- 18:15, 30 March 2022 diff hist -1,100 Urothelial carcinoma →Added Neoadjuvant ddMVAC Regimen variant #3, 6 cycles Tag: visualeditor
- 18:39, 10 March 2021 diff hist -10 Renal cell carcinoma →Regimen {{#subobject:22bc4d|Variant=1}}
- 18:39, 10 March 2021 diff hist -9 Renal cell carcinoma →Everolimus & Lenvatinib {{#subobject:e83gac|Regimen=1}}
- 18:38, 10 March 2021 diff hist -20 Renal cell carcinoma →Regimen {{#subobject:92e618|Variant=1}}
- 18:37, 10 March 2021 diff hist -36 Renal cell carcinoma →Regimen {{#subobject:92e618|Variant=1}}
- 18:37, 10 March 2021 diff hist -18 Renal cell carcinoma →Lenvatinib & Pembrolizumab {{#subobject:e83gac|Regimen=1}}
- 18:36, 10 March 2021 diff hist -19 Renal cell carcinoma →Regimen {{#subobject:22bc4d|Variant=1}}
- 18:28, 10 March 2021 diff hist +136 Renal cell carcinoma →Sunitinib monotherapy {{#subobject:b4a97a|Regimen=1}}
- 18:25, 10 March 2021 diff hist +9 Urothelial carcinoma →Locally advanced or metastatic disease, platinum and immune checkpoint inhibitor refractory
- 18:23, 10 March 2021 diff hist +8 Urothelial carcinoma →Locally advanced or metastatic disease, platinum-refractory
- 00:48, 10 March 2021 diff hist +5,027 Renal cell carcinoma Added Clear Trial Tag: visualeditor
- 00:09, 10 March 2021 diff hist +3 Urothelial carcinoma →Locally advanced or metastatic disease, maintenance after first-line therapy
- 00:06, 10 March 2021 diff hist -4,114 Urothelial carcinoma →Reorganized sections and moved salvage Atezolizumab to archive Tag: visualeditor
- 23:54, 9 March 2021 diff hist +4,103 Urothelial carcinoma - historical →Metastatic disease, subsequent lines of therapy Tag: visualeditor
- 23:06, 29 October 2020 diff hist +34 Urothelial carcinoma →Regimen {{#subobject:473057|Variant=1}}
- 23:05, 29 October 2020 diff hist +34 Urothelial carcinoma →Regimen {{#subobject:415bc7|Variant=1}}
- 23:04, 29 October 2020 diff hist +3 Urothelial carcinoma →Regimen {{#subobject:415bc7|Variant=1}}
- 23:03, 29 October 2020 diff hist -37 Urothelial carcinoma →Regimen {{#subobject:473057|Variant=1}}
- 23:03, 29 October 2020 diff hist +36 Urothelial carcinoma →Regimen {{#subobject:473057|Variant=1}}
- 23:01, 29 October 2020 diff hist +143 Urothelial carcinoma Tag: visualeditor-switched
- 22:55, 29 October 2020 diff hist +37 Urothelial carcinoma Tag: visualeditor-switched
- 15:37, 14 October 2020 diff hist +1,484 Prostate cancer →Triptorelin & Radiotherapy #subobject:611758 Tag: visualeditor
- 21:23, 5 October 2020 diff hist +554 Urothelial carcinoma →Supportive Medications Tag: visualeditor
- 17:20, 30 January 2020 diff hist +2,111 Diffuse large B-cell lymphoma →Added polatuzumab vedotin citation Tag: visualeditor
- 08:32, 29 January 2020 diff hist -2 Urothelial carcinoma →Regimen #subobject:415bc7 Tag: visualeditor
- 01:10, 22 January 2020 diff hist +2,725 Follicular lymphoma →Relapsed or refractory, non-randomized or retrospective data: Added duvelisib for relapsed/refractory disease (DYNAMO study) Tag: visualeditor
- 23:37, 8 January 2020 diff hist +34 Urothelial carcinoma renamed intravesical therapy nmbic/intravesical therapy given pembro regimen Tag: visualeditor
- 23:34, 8 January 2020 diff hist +1,318 Urothelial carcinoma Added pembrolizumab for NMIBC based on keynote-057 abstract (FDA approved) Tag: visualeditor
- 08:11, 13 November 2019 diff hist +29 m Urothelial carcinoma →References Tag: visualeditor
- 08:10, 13 November 2019 diff hist +15 m Urothelial carcinoma →References Tag: visualeditor
- 08:09, 13 November 2019 diff hist +9 m Urothelial carcinoma →Variant #2, Atezolizumab #subobject:7ae9e3 Tag: visualeditor
- 08:08, 13 November 2019 diff hist +7 m Urothelial carcinoma →Subsequent treatment Tag: visualeditor
- 08:06, 13 November 2019 diff hist +4,542 Urothelial carcinoma Added neoadjuvant immune checkpoint inhibitors Tag: visualeditor